Malaysia Drug Regulators See Harmonization As Long-term Plus For Domestic Industry
This article was originally published in PharmAsia News
Executive Summary
Malaysia’s National Pharmaceutical Control Board sees harmonization as opening doors for investment and local manufacturers to gain markets regionally and abroad.